First Indian MRNA Vaccine Gets Nod For Phase 2/3 Trials
[email protected]08 Sep, 2021News
India's first mRNA vaccine HGCO19 received DCGI nod for Phase II/III clinical trials on Tuesday. The Covid-19 vaccine has been developed by Gennova Biopharmaceuticals Ltd, a Pune-based biotechnology company in partnership with the Department of Biotechnology.
Related Bookmarks
- India's First MRNA Covid Vaccine Safe In Early Trials, Say Regulators
- click to read more
- Adtech Leader Ezoic to Invest $12.4 Million Directly in Customers
- Digital Marketing Leader Sojern Partners with Roiback
- Drips Unveils Conversational AI Platform at Contact.io Conference
- Oxford brunch Bar | Tasty & healthy breakfast | Breakfast brunch bar
- https://www.stattimes.com/news/bbam-to-lease-two-airbus-a321p2f-to-lufthansa-cargo-air-cargo/
- Different Types of Tyre Treads and Their Uses
- Bitcoin Profit
- GEODIS in Hong Kong is accredited as an Authorized Economic Operator
Recent Profiles
Uu88 Krd
Abc8
Hdbet Yachts
Karlsen Hvass
Howell Bentley
Bach Grantham
S29
Slotvip
Goodman Bruun
Blackburn Kjeldgaard